Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Glenview Trust co

Glenview Trust co lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the 4th quarter, Holdings Channel reports. The firm owned 111,376 shares of the medical equipment provider’s stock after selling 1,794 shares during the quarter. Intuitive Surgical comprises 1.1% of Glenview Trust co’s portfolio, making the stock its 22nd largest holding. Glenview Trust co’s holdings in Intuitive Surgical were worth $58,134,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the 4th quarter worth about $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the third quarter worth about $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on ISRG shares. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $484.44 on Friday. The firm’s fifty day simple moving average is $567.46 and its 200-day simple moving average is $531.60. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market capitalization of $172.55 billion, a price-to-earnings ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.